When Immunotherapy Works Even With Low PD-L1 Expression
While PD-L1 testing is widely used to guide immunotherapy decisions, a low or negative PD-L1 result does not necessarily mean […]
Precision Oncology
Precision Oncology
The Role of PD-L1 Testing Before Starting Immunotherapy
PD-L1 testing is an important biomarker assessment used to guide the use of immunotherapy in several cancers, particularly lung cancer
Precision Oncology
How Molecular Profiling Influences Treatment Decisions in Lung Cancer
Molecular profiling in lung cancer identifies specific genetic alterations within a tumor that determine which therapy is most biologically appropriate.